Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

<table>Kaplan-Meier estimates for biochemical progression-free survival for the two fractionation schedules, 57 Gy in 19 fractions and 60 Gy in 20 fractions.</table>

Prostate Cancer

fig2

Figure 2

Figure 2: Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity 